Preferred Label : R-COPADM Regimen;
NCIt synonyms : Cyclophosphamide/Vincristine/Prednisone/Doxorubicin/Methotrexate Plus Rituximab; Rituximab/Cyclophosphamide/Vincristine/Prednisone/Doxorubicin/Methotrexate; COPADM Plus Rituximab; Cyclophosphamide/Doxorubicin/Methotrexate/Prednisone/Rituximab/Vincristine; Rituximab/Cyclophosphamide/Oncovin/Prednisone/Adriamycin/Methotrexate;
NCIt related terms : R-COPADM (rituximab-arrx); R-COPADM (rituximab-pvvr); R-COPADM (rituximab-blit); R-COPADM (rituximab-rixa); R-COPADM (rituximab-rixi); R-COPADM (rituximab-rite); R-COPADM (rituximab-abbs); R-COPADM;
NCIt definition : A regimen consisting of rituximab plus cyclophosphamide, doxorubicin, methotrexate,
prednisone, and vincristine that may be used in the treatment of Burkitt lymphoma
and diffuse large B-cell lymphoma (DLBCL).;
NCI Metathesaurus CUI : CL1926987;
Codes from synonyms : 128048; 128205; 128676; 10542; 127734; 127891; 128519; 128362;
Origin ID : C204797;
UMLS CUI : C5907881;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
